Advertisement

Annals of Surgical Oncology

, Volume 26, Issue 6, pp 1909–1915 | Cite as

Tumor Volume Index as a Prognostic Factor in Patients after Curative Esophageal Cancer Resection

  • Hiroshi Miyamoto
  • Chikara KunisakiEmail author
  • Sho Sato
  • Yusaku Tanaka
  • Kei Sato
  • Takashi Kosaka
  • Norio Yukawa
  • Hirotoshi Akiyama
  • Yusuke Saigusa
  • Itaru Endo
Thoracic Oncology

Abstract

Background

The tumor, node, metastasis classification system for staging esophageal cancer does not include tumor volume although it may be an important prognostic factor. We evaluated the prognostic value of tumor volume in esophageal cancer.

Methods

We performed a retrospective study in patients with histologically confirmed primary esophageal cancer who underwent curative esophagectomy at our facility between April 1992 and December 2013. The Tumor Depth Parameter (TDP) was defined as mucosa = 1, submucosa = 2, muscularis propria = 3, adventitia = 4, and invasion into adjacent organs = 5. The pathological Tumor Volume Index (TVI) was defined as the major axis × the minor axis × TDP. The appropriate tumor diameter and TVI cutoff values were determined by the Youden index obtained from the receiver operating characteristic curve. Prognostic factors for overall survival were evaluated by univariate analysis and Cox proportional hazards regression models.

Results

We enrolled 302 patients. In the univariate analysis, patient age and sex, thoracoscopic surgery, tumor depth of invasion and diameter, lymph node metastasis, and the TVI were significantly associated with overall survival. In our multivariate analysis, patient age and sex, thoracoscopic surgery, lymph node metastasis, and the TVI were independently associated with overall survival.

Conclusions

The pathological TVI was an independent prognostic factor in patients with esophageal carcinoma and could be included in the staging system of esophageal cancer.

Notes

Disclosure

Hiroshi Miyamoto has no disclosures to declare.

Supplementary material

10434_2019_7308_MOESM1_ESM.docx (17 kb)
Supplementary material 1 (DOCX 13 kb)
10434_2019_7308_MOESM2_ESM.tif (108 kb)
Supplementary Fig. 1 Preoperative TVI assessed by the imaging modalities was correlated with the pathological TVI (r = 0.665, P < 0.001) (TIFF 107 kb)

References

  1. 1.
    Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.CrossRefGoogle Scholar
  2. 2.
    Wittekind C, Yamasaki S. Digestive System Tumours–Oesophagus including oesophagogastric junction. In: Sobin LH, Gospodarowicz MK, Wittekind C (eds) TNM classification of malignant tumours, 7th edn. New York: Wiley-Blackwell, 2009:66.Google Scholar
  3. 3.
    Kunisaki C, Makino H, Takagawa R, et al. Tumor diameter as a prognostic factor in patients with gastric cancer. Ann Surg Oncol. 2008; 15:1959–67.CrossRefGoogle Scholar
  4. 4.
    Yendamuri S, Swisher SG, Correa AM, et al. Esophageal tumor length is independently associated with long-term survival. Cancer. 2009;115:508–16.CrossRefGoogle Scholar
  5. 5.
    Choi JY, Jang HY, Shim YM, et al. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. J Nucl Med. 2004;45:1843–50.Google Scholar
  6. 6.
    Igaki H, Kato H, Tachimori Y, Sato H, Daiko H, Nakanishi Y. Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg. 2001;19:887–93.CrossRefGoogle Scholar
  7. 7.
    Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305–13.CrossRefGoogle Scholar
  8. 8.
    Yu Y, Guan H, Xing LG, Xiang YB. Role of gross tumor volume in the prognosis of non-small cell lung cancer treated with 3D conformal radiotherapy: a meta-analysis. Clin Ther. 2015;37:2256–66.CrossRefGoogle Scholar
  9. 9.
    Issa MR, Samuels SE, Bellile E, Shalabi FL, Eisbruch A, Wolf G. Tumor volumes and prognosis in laryngeal cancer. Cancers (Basel). 2015;7:2236–61.CrossRefGoogle Scholar
  10. 10.
    Schiavina R, Borghesi M, Chessa F, et al. The prognostic impact of tumor size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma. Clin Genitourin Cancer. 2015;13:e235–41.CrossRefGoogle Scholar
  11. 11.
    Kim KH, Lim SK, Shin TY, et al. Tumor volume adds prognostic value in patients with organ-confined prostate cancer. Ann Surg Oncol. 2013; 20:3133–9.CrossRefGoogle Scholar
  12. 12.
    Chen Y, Zhang Z, Jiang G, Zhao K. Gross tumor volume is the prognostic factor for squamous cell esophageal cancer patients treated with definitive radiotherapy. J Thorac Dis. 2016;8:1155–61.CrossRefGoogle Scholar
  13. 13.
    Créhange G, Bosset M, Lorchel F, et al. Tumor volume as outcome determinant in patients treated with chemoradiation for locally advanced esophageal cancer. Am J Clin Oncol. 2006;29:583–7.CrossRefGoogle Scholar
  14. 14.
    Hatt M, Visvikis D, Albarghach NM, Tixier F, Pradier O, Cheze-le Rest C. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology. Eur J Nucl Med Mol Imaging. 2011;38:1191–202.CrossRefGoogle Scholar
  15. 15.
    Hyun SH, Choi JY, Shim YM, et al. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol. 2010;17:115–22.CrossRefGoogle Scholar
  16. 16.
    Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg. 1994;81:410–3.CrossRefGoogle Scholar
  17. 17.
    Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer. 2002;95:1434–43.CrossRefGoogle Scholar
  18. 18.
    Ellis FH Jr, Heatley GJ, Krasna MJ, Williamson WA, Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg. 1997;113:836–46.CrossRefGoogle Scholar
  19. 19.
    Korst RJ, Rusch VW, Venkatraman E, et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg. 1998;115:660–9.CrossRefGoogle Scholar
  20. 20.
    Gill PG, Denham JW, Jamieson GG, Devitt PG, Yeoh E, Olweny C. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol. 1992;10:1037–43.CrossRefGoogle Scholar
  21. 21.
    Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol. 2006;24:4347–55.CrossRefGoogle Scholar
  22. 22.
    Tullie LG, Sohn HM, Zylstra J, et al. A role for tumor volume assessment in resectable esophageal cancer. Ann Surg Oncol. 2016;23:3063–70.CrossRefGoogle Scholar
  23. 23.
    Chan DSY, Fielding P, Roberts SA, Reid TD, Ellis-Owen R, Lewis WG. Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer. Clin Radiol. 2013; 68:352–7.CrossRefGoogle Scholar
  24. 24.
    Kauppila JH, Wahlin K, Lagergren P, Lagergren J. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma. Int J Cancer.  https://doi.org/10.1002/ijc.31840.Google Scholar
  25. 25.
    Takeno S, Takahashi Y, Moroga T, Kawahara K, Yamashita Y, Ohtaki M. Retrospective study using the propensity score to clarify the oncologic feasibility of thoracoscopic esophagectomy in patients with esophageal cancer. World J Surg. 2013;37:1673–80.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Hiroshi Miyamoto
    • 1
  • Chikara Kunisaki
    • 1
    Email author
  • Sho Sato
    • 1
  • Yusaku Tanaka
    • 1
  • Kei Sato
    • 1
  • Takashi Kosaka
    • 2
  • Norio Yukawa
    • 1
  • Hirotoshi Akiyama
    • 2
  • Yusuke Saigusa
    • 3
  • Itaru Endo
    • 2
  1. 1.Department of Surgery, Gastroenterological CenterYokohama City UniversityYokohamaJapan
  2. 2.Department of Gastroenterological Surgery, Graduate School of MedicineYokohama City UniversityYokohamaJapan
  3. 3.Department of Biostatistics, Graduate School of MedicineYokohama City UniversityYokohamaJapan

Personalised recommendations